US Obesity Rates Hit Record High Amid New Drug Hope
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
Category : Search result: Wegovy
Wegovy's hidden mental benefits revealed
Stanford psychologist reveals how weight-loss drugs like Wegovy create profound mental changes that could revolutionise obesity treatment beyond mere physical transformation.
Gyms cash in on weight-loss jab muscle crisis
As slimming injections surge in popularity, fitness centres report booming business from users fighting to preserve muscle mass while shedding pounds
Weight Loss Injections Cut Heart Attack Risk
Groundbreaking research shows popular weight loss medications like Wegovy and Ozempic dramatically reduce cardiovascular events, offering dual protection for patients.
Academics Urge Lower BMI for Wegovy Access
University College London researchers call for expanding Wegovy access after revealing compelling new evidence that could change NHS obesity treatment guidelines.
Weight loss jabs boost heart health, study finds
Groundbreaking research shows popular weight loss injections like Wegovy and Ozempic significantly reduce cardiovascular risks alongside promoting weight loss, offering new hope for millions.
Weight loss jabs slash heart risk in UK study
Groundbreaking research reveals popular weight loss injections Wegovy and Ozempic significantly reduce heart attack and stroke risks, offering dual benefits for millions struggling with obesity.
Novo Nordisk Board Exodus: Chairman & 6 Directors Depart
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
Wegovy Gains Medicaid Coverage in US States
Groundbreaking obesity medication Wegovy gains Medicaid coverage across multiple American states, marking a significant shift in healthcare policy for weight management treatments.
Boots withdraws 'fat jab' weight loss injection service
High street pharmacy chain Boots has suspended its popular 'fat jab' weight loss injection service following overwhelming demand and supply shortages, leaving thousands of customers seeking alternatives.
Ozempic & Wegovy Cause Dangerous Scan Complications
Groundbreaking research reveals popular weight-loss drugs Ozempic and Wegovy are causing dangerous stomach complications during medical scans, prompting urgent NHS warnings.
Weight Loss Drugs Linked to Reduced Alcohol Cravings
Groundbreaking research reveals GLP-1 medications prescribed for weight management are showing unexpected benefits in reducing alcohol consumption among users, with some reporting complete loss of interest in drinking.
Wegovy and Mounjaro Weight Loss Jabs Available in UK
Groundbreaking weight loss injections Wegovy and Mounjaro are transforming obesity treatment in the UK, offering new hope for thousands struggling with weight management through both NHS and private healthcare providers.
Weight Loss Jabs Show Revolutionary Results in UK Study
Groundbreaking research shows obesity injections like Mounjaro and Wegovy deliver unprecedented weight loss results, potentially transforming NHS treatment approaches and offering new hope for millions struggling with weight management.
1 in 20 Brits use weight loss jabs as demand soars
Groundbreaking research reveals nearly 5% of UK adults are turning to revolutionary weight loss injections like Wegovy and Mounjaro, with overwhelming majority paying privately amid NHS supply constraints.
Weight loss jabs slash early death risk by 20%
Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.
Ozempic & Wegovy: Hidden Dangers Revealed in Scans
Groundbreaking medical imaging uncovers alarming side effects of popular weight-loss drugs Ozempic and Wegovy that patients need to know about.
Weight-loss jabs may hide cancer in medical scans
Groundbreaking research reveals GLP-1 agonists like Ozempic and Wegovy may cause misleading results on CT and PET scans, potentially hiding cancers and leading to dangerous misdiagnoses.
Weight Loss Jabs: The Reality When Treatment Stops
New medical research reveals the sobering reality for patients discontinuing popular weight loss injections like Ozempic and Wegovy, with most regaining significant weight within months.
Costco Sells Wegovy & Ozempic in UK Pharmacies
Exclusive: Costco pharmacies begin selling revolutionary weight loss injections Wegovy and Ozempic at competitive prices, making groundbreaking treatments more accessible across Britain.
Costco Discounts Ozempic and Wegovy Weight Loss Drugs
Warehouse giant Costco is now offering substantial discounts on popular weight loss medications Ozempic and Wegovy, making groundbreaking treatments more accessible to consumers across the UK.
Ozempic October: Weight-Loss Drug Revolution in UK
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Mounjaro Beats Wegovy in Weight Loss Study
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
Weight-Loss Jabs: The Profit-Driven Health Crisis
Exclusive investigation reveals how drug companies are profiting from body shame through Ozempic and Wegovy injections, while eating disorder experts warn of potentially devastating health consequences.
Pfizer Revives Weight-Loss Pill to Challenge Obesity Drug Leaders
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
Weight Loss Jabs: NHS Faces £20 Billion Crisis
Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
NHS weight-loss drugs could cost double entire GP budget
Exclusive: The NHS faces a financial timebomb as new analysis reveals prescribing weight-loss drugs like Wegovy could cost twice the entire current GP prescribing budget, sparking a national rationing debate.
Wegovy Weight Loss Pill Shows 'Substantial' Results in UK
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
Ozempic's Hidden Flaw: Missing Emotional Eating Support
Medical experts reveal why miracle weight-loss drugs like Ozempic are failing to address the psychological roots of emotional eating, calling for integrated mental health support alongside pharmaceutical treatments.
Ozempic Found to Curb Emotional Eating in Brain Breakthrough
Groundbreaking research reveals that blockbuster weight-loss jabs do more than suppress appetite—they may fundamentally change the brain's response to food, offering new hope for tackling compulsive eating disorders.
Page 1 of 4